We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 3,427 results
  1. Non-canonical antigens are the largest fraction of peptides presented by MHC class I in mismatch repair deficient murine colorectal cancer

    Background

    Immunotherapy based on checkpoint inhibitors is highly effective in mismatch repair deficient (MMRd) colorectal cancer (CRC). These tumors...

    Giuseppe Rospo, Rosaria Chilà, ... Alberto Bardelli in Genome Medicine
    Article Open access 19 January 2024
  2. Non-canonical transcriptional regulation of the poor prognostic factor UGT2B17 in chronic lymphocytic leukemic and normal B cells

    Background

    High expression of the glycosyltransferase UGT2B17 represents an independent adverse prognostic marker in chronic lymphocytic leukemia...

    Michèle Rouleau, Lyne Villeneuve, ... Chantal Guillemette in BMC Cancer
    Article Open access 02 April 2024
  3. OTUB1 accelerates hepatocellular carcinoma by stabilizing RACK1 via its non-canonical ubiquitination

    Background

    Dysregulated ubiquitination modification occupies a pivotal role in hepatocellular carcinoma (HCC) tumorigenesis and progression. The...

    Liqun Peng, Tiangen Wu, ... Yufeng Yuan in Cellular Oncology
    Article Open access 05 February 2024
  4. Cancer Antigens: Sources, Generation, and Presentation

    Immune surveillance by T cells requires antigen presentation by molecules encoded by MHC (major histocompatibility complex) class I and class II...
    Living reference work entry 2023
  5. Thinking outside the box: non-canonical targets in multiple sclerosis

    Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system that causes demyelination, axonal degeneration and astrogliosis,...

    Laura Bierhansl, Hans-Peter Hartung, ... Sven G. Meuth in Nature Reviews Drug Discovery
    Article 06 June 2022
  6. LINE1 are spliced in non-canonical transcript variants to regulate T cell quiescence and exhaustion

    How gene expression is controlled to preserve human T cell quiescence is poorly understood. Here we show that non-canonical splicing variants...

    Federica Marasca, Shruti Sinha, ... Beatrice Bodega in Nature Genetics
    Article 17 January 2022
  7. Long-term retention of antigens in germinal centers is controlled by the spatial organization of the follicular dendritic cell network

    Germinal centers (GCs) require sustained availability of antigens to promote antibody affinity maturation against pathogens and vaccines. A key...

    Ana Martínez-Riaño, Shenshen Wang, ... Pavel Tolar in Nature Immunology
    Article 13 July 2023
  8. Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells

    Few cancers can be targeted efficiently by engineered T cell strategies. Here, we show that γδ T cell antigen receptor (γδ TCR)-mediated cancer...

    Patricia Hernández-López, Eline van Diest, ... Jürgen Kuball in Nature Immunology
    Article 27 November 2023
  9. Peripheral blood non-canonical small non-coding RNAs as novel biomarkers in lung cancer

    One unmet challenge in lung cancer diagnosis is to accurately differentiate lung cancer from other lung diseases with similar clinical symptoms and...

    Wanjun Gu, Junchao Shi, ... Tong Zhou in Molecular Cancer
    Article Open access 12 November 2020
  10. Progression of monoclonal gammopathy of undetermined significance to multiple myeloma is associated with enhanced translational quality control and overall loss of surface antigens

    Background

    Despite significant advancements in treatment strategies, multiple myeloma remains incurable. Additionally, there is a distinct lack of...

    Sigrid Ravn Berg, Aida Dikic, ... Geir Slupphaug in Journal of Translational Medicine
    Article Open access 07 June 2024
  11. Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses

    Inducing antigen-specific tolerance during an established immune response typically requires non-specific immunosuppressive signalling molecules....

    Andrew C. Tremain, Rachel P. Wallace, ... Jeffrey A. Hubbell in Nature Biomedical Engineering
    Article 07 September 2023
  12. Low-Field Magnetic Stimulation Accelerates the Differentiation of Oligodendrocyte Precursor Cells via Non-canonical TGF-β Signaling Pathways

    Demyelination and oligodendrocyte loss are characteristic changes in demyelinating disorders. Low-field magnetic stimulation (LFMS) is a novel...

    Natalia Dolgova, Zelan Wei, ... Yanbo Zhang in Molecular Neurobiology
    Article 10 October 2020
  13. The small tumor antigen of Merkel cell polyomavirus accomplishes cellular transformation by uniquely localizing to the nucleus despite the absence of a known nuclear localization signal

    Background

    Merkel Cell Carcinoma (MCC) is an aggressive skin cancer that is three times deadlier than melanoma. In 2008, it was found that 80% of MCC...

    Kaira R. Thevenin, Isabella S. Tieche, ... Kristine N. Dye in Virology Journal
    Article Open access 03 June 2024
  14. In-vivo expressed Mycobacterium tuberculosis antigens recognised in three mouse strains after infection and BCG vaccination

    Novel tuberculosis (TB)-vaccines preferably should (i) boost host immune responses induced by previous BCG vaccination and (ii) be directed against Myc...

    Mariateresa Coppola, Fabienne Jurion, ... Tom H. M. Ottenhoff in npj Vaccines
    Article Open access 03 June 2021
  15. Non-mutational neoantigens in disease

    The ability of mammals to mount adaptive immune responses culminating with the establishment of immunological memory is predicated on the ability of...

    Lawrence J. Stern, Cristina Clement, ... Laura Santambrogio in Nature Immunology
    Article 02 January 2024
  16. Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program

    Background

    The Tumor Microenviroment (TME) is a complex milieu that is increasingly recognized as a key factor in multiple stages of disease...

    Massimo Granai, Lucia Mundo, ... Teresa Marafioti in Infectious Agents and Cancer
    Article Open access 06 May 2020
  17. Fibroblasts as a source of self-antigens for central immune tolerance

    Fibroblasts are one of the most common but also neglected types of stromal cells, the heterogeneity of which underlies the specific function of...

    Takeshi Nitta, Masanori Tsutsumi, ... Hiroshi Takayanagi in Nature Immunology
    Article 24 August 2020
  18. MR1 antigen presentation to MAIT cells and other MR1-restricted T cells

    MHC antigen presentation plays a fundamental role in adaptive and semi-invariant T cell immunity. Distinct MHC molecules bind antigens that differ in...

    Hamish E. G. McWilliam, Jose A. Villadangos in Nature Reviews Immunology
    Article 29 September 2023
  19. Second messenger 2'3'-cyclic GMP-AMP (2'3'-cGAMP): the cell autonomous and non-autonomous roles in cancer progression

    Cytosolic double-stranded DNA (dsDNA) is frequently accumulated in cancer cells due to chromosomal instability or exogenous stimulation. Cyclic...

    **ao-yu Ma, Man-man Chen, Ling-hua Meng in Acta Pharmacologica Sinica
    Article 04 January 2024
Did you find what you were looking for? Share feedback.